1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Reference: new trials by email Literature Review of Reference trials Research Report on Reference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer Lupin's Pegfilgrastim, Neulasta® - Breast Cancer | Phase 4 | Completed | Lupin Ltd. | 138 | 2018-03-06 | 2021-06-15 |
Breast Neoplasms (1)
Lupin Ltd. (1)
India (1)